Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease.
McCarroll SA,
Huett A,
Kuballa P,
Chilewski SD,
Landry A,
Goyette P,
Zody MC,
Hall JL,
Brant SR,
Cho JH,
Duerr RH,
Silverberg MS,
Taylor KD,
Rioux JD,
Altshuler D,
Daly MJ,
Xavier RJ.
[1] Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, Boston, Massachusetts 02114, USA [2] Molecular Biology Department, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, Boston, Massachusetts 02114, USA. [3] The Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.
Following recent success in genome-wide association studies, a critical focus of human genetics is to understand how genetic variation at implicated loci influences cellular and disease processes. Crohn's disease (CD) is associated with SNPs around IRGM, but coding-sequence variation has been excluded as a source of this association. We identified a common, 20-kb deletion polymorphism, immediately upstream of IRGM and in perfect linkage disequilibrium (r(2) = 1.0) with the most strongly CD-associated SNP, that causes IRGM to segregate in the population with two distinct upstream sequences. The deletion (CD risk) and reference (CD protective) haplotypes of IRGM showed distinct expression patterns. Manipulation of IRGM expression levels modulated cellular autophagy of internalized bacteria, a process implicated in CD. These results suggest that the CD association at IRGM arises from an alteration in IRGM regulation that affects the efficacy of autophagy and identify a common deletion polymorphism as a likely causal variant.
PMID: 18724369 [PubMed - as supplied by publisher]